Take a look at this tweet, 'year end' is any day now:
$TXTM Protext Pharma taking steps to restructure preferred stock already issued as company contemplates strategic acquisition in emerging cannabis related space. Result would make available approximately 30% of already issued Preferred stock and should be completed by year end.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.